Recent Insider Transactions - Crinetics Pharmaceuticals (NASDAQ: CRNX)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ CRNX Crinetics Pharmaceuticals

Pizzuti Dana / officer: Chief Med and Dev Officer

03/19/2025

Sell

$34.17

2,388

$82K

72,360

NASDAQ CRNX Crinetics Pharmaceuticals

Pizzuti Dana / officer: Chief Med and Dev Officer

03/19/2025

Sell

$34.83

127

$4K

72,233

NASDAQ CRNX Crinetics Pharmaceuticals

Knight Jeff E. / officer: Chief Operating Officer

03/19/2025

Sell

$34.17

6,801

$232K

87,852

NASDAQ CRNX Crinetics Pharmaceuticals

Knight Jeff E. / officer: Chief Operating Officer

03/19/2025

Sell

$34.83

361

$13K

87,491

NASDAQ CRNX Crinetics Pharmaceuticals

Betz Stephen F. / officer: Chief Scientific Officer

03/19/2025

Sell

$34.17

5,479

$187K

108,879

NASDAQ CRNX Crinetics Pharmaceuticals

Betz Stephen F. / officer: Chief Scientific Officer

03/19/2025

Sell

$34.83

291

$10K

108,588

NASDAQ CRNX Crinetics Pharmaceuticals

Struthers Richard Scott / director, officer: President & CEO

03/19/2025

Sell

$34.17

16,463

$563K

330,022

NASDAQ CRNX Crinetics Pharmaceuticals

Struthers Richard Scott / director, officer: President & CEO

03/19/2025

Sell

$34.83

875

$30K

329,147

NASDAQ CRNX Crinetics Pharmaceuticals

Schilke Tobin / officer: Chief Financial Officer

03/10/2025

Buy

$33.75

80,000

$2.700M

80,000

NASDAQ CRNX Crinetics Pharmaceuticals

Struthers Richard Scott / director, officer: President & CEO

02/20/2025

Buy

$36.86

313,000

$11.537M

313,000

NASDAQ CRNX Crinetics Pharmaceuticals

Knight Jeff E. / officer: Chief Operating Officer

02/20/2025

Buy

$36.86

65,000

$2.396M

65,000

NASDAQ CRNX Crinetics Pharmaceuticals

Pizzuti Dana / officer: Chief Med and Dev Officer

02/20/2025

Buy

$36.86

65,000

$2.396M

65,000

NASDAQ CRNX Crinetics Pharmaceuticals

Betz Stephen F. / officer: Chief Scientific Officer

02/20/2025

Buy

$36.86

65,000

$2.396M

65,000